- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Eight UK-based AstraZeneca employees ‘liked’ a US LinkedIn post linking to an Enhertu press release. The PMCPA ruled this proactively disseminated promotional…
Complaint about Trixeo promotional claims (spacer use, lung deposition %, and missing Symbicort PI). PMCPA Panel found no breach of the 2021…
At ERS 2022, GSK-sponsored symposium slides on a COPD network meta-analysis were ruled misleading/unsubstantiated (Clauses 6.1, 6.2, 5.1). Allegations about MSLs acting…
Otsuka’s “Therapy Areas in Europe” webpage still referenced working with partner Akebia on CKD anaemia after the agreement ended. PMCPA ruled the…
PMCPA found Merck Serono failed to maintain high standards after two event co-chairs’ consultancy agreements were not agreed/signed in advance of services.…
Ex-employee alleged BI/Lilly alliance PMAP SOP and training were not accessible/controlled and that “agreements outside PMAP” existed. Panel found allegations not evidenced;…
PMCPA case AUTH/3870/1/24 against AstraZeneca concerned allegations about clinical trial material. The matter was found outwith the scope of the ABPI Code;…
Complaint alleged MART references on AstraZeneca’s SENTINEL Plus HCP website indirectly promoted Symbicort and therefore needed PI and an AE reporting statement.…
Complaint alleged GSK sponsorship of an HCP event wasn’t disclosed on the homepage or registration pages. Panel found sponsorship was sufficiently clear…
Two Idorsia banner ads for Quviviq used the term “chronic insomnia”. Complaint alleged off-licence promotion vs SmPC. Panel found authoritative definitions aligned…
Pfizer UK’s 2020 Twitter thread on Phase 3 Covid-19 vaccine results (plus linked BioNTech content and press release) was ruled promotional before…
Jazz funded a patient organisation’s “Family Guide” via unrestricted grants. The funding declaration appeared in small font on page 5 and the…
Complaint challenged a Blenrep website claim (“generally well tolerated and manageable safety profile”) as misleading/unqualified. Panel found the claim sufficiently supported and…
A UK health professional complained about Janssen’s HCP website. The Panel found some prescribing information was out-of-date, one graph exaggerated differences, and…
A GP complained that he continued to receive promotional emails after opting out. A third-party agency failed to remove his details, and…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.